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Nucleotides contribute to the sensation of acute and chronic pain, but it remained enigmatic which G
protein-coupled nucleotide (P2Y) receptors and associated signaling cascades are involved. To resolve
this issue, nucleotides were applied to dorsal root ganglion neurons under current- and voltage-clamp.
Adenosine triphosphate (ATP), adenosine diphosphate (ADP), and uridine triphosphate (UTP), but not uri-
dine diphosphate (UDP), depolarized the neurons and enhanced action potential ﬁring in response to cur-
rent injections. The P2Y2 receptor preferring agonist 2-thio-UTP was equipotent to UTP in eliciting these
effects. The selective P2Y1 receptor antagonist MRS2179 largely attenuated the excitatory effects of ADP,
but left those of 2-thio-UTP unaltered. Thus, the excitatory effects of the nucleotides were mediated by 2
different P2Y receptors, P2Y1 and P2Y2. Activation of each of these 2 receptors by either ADP or 2-thio-
UTP inhibited currents through KV7 channels, on one hand, and facilitated currents through TRPV1 chan-
nels, on the other hand. Both effects were abolished by inhibitors of phospholipase C or Ca2+-ATPase and
by chelation of intracellular Ca2+. The facilitation of TRPV1, but not the inhibition KV7 channels, was pre-
vented by a protein kinase C inhibitor. Simultaneous blockage of KV7 channels and of TRPV1 channels pre-
vented nucleotide-induced membrane depolarization and action potential ﬁring. Thus, P2Y1 and P2Y2
receptors mediate an excitation of dorsal root ganglion neurons by nucleotides through the inhibition
of KV7 channels and the facilitation of TRPV1 channels via a common bifurcated signaling pathway relying
on an increase in intracellular Ca2+ and an activation of protein kinase C, respectively.
 2011 International Association for the Study of Pain. Published by Elsevier B.V.
Open access under CC BY-NC-ND license.1. Introduction
Sensory dorsal root ganglion (DRG) neurons mediate the sensa-
tion of acute and chronic pain. Acute pain is elicited by thermal,
mechanical, or chemical stimuli, whereas chronic pain results from
the sensitization of sensory neurons most commonly due to
inﬂammatory reactions. The sensitization is mediated by an
‘‘inﬂammatory soup’’ containing a plethora of signaling molecules,
such as cytokines, neurotrophins, bradykinin, prostaglandins, and
nucleotides. Interestingly, most analgesics target the synthesis,
the release, or the receptors of these inﬂammatory mediators, as
exempliﬁed by inhibitors of cyclooxygenases, such as acetylsali-
cylic acid [4].
Adenosine triphosphate (ATP) and other nucleotides are re-
leased from all cells in response to a variety of stimuli and mediate
their effects via a class of receptors termed P2 [25]: P2X receptorstudy of Pain. Published by Elsevie
ysiology and Pharmacology,
, A-1090 Wien, Austria. Tel.:
S. Boehm).are ATP-gated cation channels composed of 3 of a repertoire of at
least 7 different subunits (P2X1 to P2X7) that assemble in homo-
mers or heteromers. P2Y receptors are G protein-coupled receptors,
and 8 different subtypes have been identiﬁed (P2Y1,2,4,6,11,12,13,14)
[1,13]. Sensory neurons express both P2X and P2Y receptors; in
DRG neurons, the presence of all known P2X subunits but P2X7
has been reported, and the predominating receptors are P2X3 hom-
omers and P2X2/3 heteromers [13,47]. Furthermore, the expression
of P2X3 is altered under conditions of chronic pain [41,48]. There-
fore, P2X3 receptors are considered promising targets for novel
analgesics [12,44].
For P2Y receptors, expression of P2Y1,2,4,6,12,13,14 has been re-
ported in DRG neurons [24,28,35]. Activation of P2Y2 receptors ex-
cites DRG neurons, but the underlying mechanisms remained
obscure [30]. The respective agonists, ATP and uridine triphosphate
[UTP], trigger increases in intracellular Ca2+ and the release of cal-
citonin gene-related peptide [36]. UTP has also been reported to
activate cutaneous C-ﬁbers [38]. Activation of P2Y1 receptors, in
contrast, was suggested to mediate analgesic effects through an
inhibition of voltage-activated Ca2+ channels (VACCs), which re-
sults in a reduction of transmitter release onto dorsal horn neuronsr B.V. Open access under CC BY-NC-ND license.
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rather mediated by P2Y12 instead of P2Y1 receptors [28]. Moreover,
P2Y1 receptors were reported to mediate hyperalgesia [28], and
this effect was proposed to be mediated by a sensitization of TRPV1
channels [40]. Later on, however, the P2Y receptor involved in the
sensitization of TRPV1 channels by nucleotides was reported to be
P2Y2 [27,31]. In addition, nucleotides were suggested to enhance
nociception by modulating voltage-activated Na+ channels in
DRG neurons [33]. Thus, it remained quite controversial which
P2Y receptor subtypes control the functions of DRG neurons and
whether the outcome is an increase or a decrease in nociception.
In addition to the modulation of voltage-activated Na+ and Ca2+
channels, P2Y receptors mediate the modulation of various neuro-
nal K+ channels, including KV7 [49], Kir3.1/3.2 channels [19], and
KCa2 channels [37]. Therefore, this study investigated which P2Y
receptors control the excitability of DRG neurons, whether the
modulation of K+ channels might contribute to this effect, and
what the underlying signaling mechanisms might be.2. Materials and methods
2.1. Materials
All the nucleotides (adenosine diphosphate [ADP], ATP, uridine
diphosphate [UDP], UTP), capsaicin, and 1,2-bis(2-aminophen-
oxy)ethane-N,N,N0,N0-tetraacetic acid tetrakis acetoxymethyl ester
(BAPTA-AM), along with bulk chemicals, were obtained from
Sigma–Aldrich (Vienna, Austria). Speciﬁc P2Y agonists and antago-
nists (2-thio-UTP and MRS 2179), iodoresiniferatoxin, U73122, and
thapsigargin were obtained from Tocris (Bristol, UK); tetrodotoxin
(TTX) was obtained from Latoxan (Rosans, France); cangrelor was a
generous gift of AstraZeneca R&D Charnwood (Loughborough, UK).
2.2. Primary cultures of DRG neurons
Primary cultures of dissociated DRG neurons from young rats
were prepared as described previously [32] with minor modiﬁca-
tions. Brieﬂy, ganglia were dissected from 10- to 12-day-old
Sprague–Dawley rats that had been killed by decapitation in full
accordance with all rules of the Austrian animal protection
law (see http://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=
Bundesnormen&Gesetzesnummer=20003541) and the Austrian
animal experiment by-laws (see http://www.ris2.bka.gv.at/
Dokumente/BgblPdf/2000_198_2/2000_198_2.pdf). Dissected gan-
glia were incubated in collagenase (1.5 mg/mL; Sigma) and dispase
(3.0 mg/mL; BoehringerMannheim, Vienna, Austria) for 30 minutes
at 37C. Then, they were incubated in trypsin (0.25% trypsin;
Worthington, Lakewood, NJ) for 15 minutes at 37C, dissociated by
trituration, and resuspended in Dulbecco modiﬁed Eagle medium
(InVitrogen, Lofer, Austria) containing 4.5 g/L glucose, 10 mg/L
insulin, 25 000 IU/L penicillin, and 25 mg/L streptomycin (InVitro-
gen), 50 lg/L nerve growth factor (R&D Systems Inc., Minneapolis,
MN), and 5% fetal calf serum (InVitrogen). Finally, dissociated cells
were seeded onto 35-mm culture dishes coated with poly D-lysine
(Sigma). The cultures were kept in a humidiﬁed 5% CO2 atmosphere
at 37C. The medium was exchanged at least once per week.
2.3. Electrophysiology
All currents or potentials were recorded at room temperature
(20C to 24C) from small-diameter DRG neurons after 1 to 2 days
in culture using an Axopatch 200B ampliﬁer and the pCLAMP 8.1
hard- and software (Molecular Devices, Sunnyvale, CA). All of the
neurons investigated displayed capsaicin-induced currents (Icaps)
and were thus assumed to provide nociceptive functions. In a fewexperiments, capsaicin-insensitive neurons were used for compar-
ison.Membrane excitability and currents through KV7 channels (IM)
or TRPV1 channels (Icaps) of DRG neurons were determined in the
perforated patch clamp mode, voltage-activated Ca2+ currents in
the whole-cell conﬁguration. Signals were low-pass ﬁltered at
5 kHz, digitized at 10 to 50 kHz, and stored on an IBM-compatible
computer. Traces were analyzed off-line by the Clampﬁt 8.2 pro-
gram (Molecular Devices). Patch electrodes were pulled (Flaming-
Brown puller, Sutter Instruments, Novato, CA) from borosilicate
glass capillaries (Science Products, Frankfurt/Main, Germany). For
perforated patch recordings, the internal solution contained (mM)
K2SO4 (75), KCl (55), MgCl2 (8), and HEPES (10), adjusted to pH
7.3 with KOH; the recording electrodes were ﬁrst front-ﬁlled with
this internal solution and then back-ﬁlled with the same solution
containing 200 lg/mL amphotericin B (in 0.8% dimethylsulfoxide
[DMSO]). For whole-cell recordings, the pipette solution consisted
of (mM) CsCl (130), tetraethylammonium chloride (20), CaCl2
(0.24), glucose (10), HEPES (10), EGTA (5), Mg-ATP (2), and
Na-GTP (2), adjusted to pH 7.3 with CsOH. The external (bathing)
solution routinely contained (mM) NaCl (140), KCl (6.0), CaCl2
(2.0), MgCl2 (2.0), glucose (20), HEPES (10), adjusted to pH 7.4 with
NaOH. For the recordings of IM and Icaps, TTX (0.5 lM) was included
to suppress voltage-activated Na+ currents. For Ca2+ current
recordings, the external solution contained (mM) tetraethylammo-
nium chloride (155), MgCl2 (0.8), CaCl2 (2.5), glucose (11), HEPES
(10), and TTX (0.0005), adjusted to pH 7.3 with KOH. Tip resistances
were between 1.5 and 3.5 MX. The resulting liquid junction
potentials were below ±10 mV and were not taken into further
consideration during experimentation or data evaluation. Drugs
were applied via a DAD-12 drug application device (Adams &
List, Westbury, NY), which permits a complete exchange of
solutions surrounding the cells being investigated within less than
100 ms [5].
To test for the effects of different nucleotides on membrane
excitability, DRG neurons were challenged by 5 increasing current
injections (0.1 to 0.5 nA), each lasting for 2 seconds. Changes in
excitability were evaluated by counting the number of action
potentials ﬁred during these 5 current injections in the absence
and presence of nucleotides, respectively.
To quantify currents through KV7 channels (IM), noninactivating
outward currents were activated by depolarizing the membrane to
30 mV. Once every 10 seconds, cells were hyperpolarized to
55 mV for 1-second periods to deactivate KV7 channels; the dif-
ferences between current amplitudes 20 ms after the onset of
hyperpolarisations and 20 ms before re-depolarization were taken
as a measure for IM [6]. Currents through TRPV1 channels were
evoked by 15-second applications of capsaicin (Icaps) to cells held
at a potential of70 mV once every 2 minutes, and the peak ampli-
tudes of these currents were quantiﬁed. Ca2+ currents were elicited
by 30-ms depolarizations from a holding potential of 80 to
10 mV at a frequency of 4 per minute. Leakage currents were cor-
rected for by an online leak subtraction protocol that applies 4
hyperpolarizing pulses before the depolarization to 10 mV; cur-
rents were quantiﬁed by measuring peak current amplitudes.
Recordingsobtained in thepresenceof nucleotides (b)were com-
pared with those measured before (a) and after (c) the presence of
thenucleotides; changes in current amplitudeswere thencalculated
as percent of control = 200  b/(a + c) or as percent inhibition =
100  [200  b/(a + c)]. For statistical comparison, such sequences
were recorded, but nucleotide solutions were replaced by solvent.
2.4. Statistics
All data are given as arithmetic means ± SEM; n values give the
numbers of single cells. Differences between 2 data points were
evaluated by the nonparametric Mann–Whitney U test or the
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points were evaluated by the nonparametric Kruskal–Wallis anal-
ysis of variance followed by a Dunn post-hoc test.
3. Results
3.1. Nucleotides increase the excitability of DRG neurons
The excitability of DRG neurons is well known to be enhanced
in the presence of a variety of inﬂammatory mediators, such as
bradykinin [26] and prostaglandins [18], which results in increased
action potential ﬁring frequencies. Moreover, changes in mem-
brane excitability of DRG neurons correlate well with changes in
nocifensive behavior [26]. Therefore, DRG neurons were investi-
gated in perforated patch recordings (to maintain the integrity of
cytosolic signaling components) in current clamp mode. To test
for the excitability of the neurons, 2-second current injections
were applied in increments of 100 pA as described, for instance,
in investigations on the effects of prostaglandins [18].
A total of 64 cells had an average membrane potential of
65.1 ± 0.8 mV. In response to the injection of 100 pA for 2 sec-
onds, none of the neurons ﬁred any action potential; with increas-
ing current injections, however, the number of elicited action
potentials increased; with 500 pA injections, for instance, the neu-
rons ﬁred 1.4 ± 0.1 action potentials per 2 seconds (n = 64; Fig. 1A).
Subsequently, the total number of action potentials ﬁred in re-
sponse to all 5 current injections will be evaluated. In the presence
of 10 lM ATP, the neurons were depolarized by about 10 mV, and
the number of action potentials elicited by the 5 consecutive peri-
ods of current injection increased to >40. After removal of ATP, the
membrane potential and the number of elicited action potentialsFig. 1. Increase in membrane excitability of rat sensory neurons caused by different nucle
and ﬁve 2-second current injections of increasing amplitudes (as shown in A) were ap
Original traces obtained before (ctrl), during (ATP), and after (wash) the application of 1
injections in the presence of ADP, ATP, UDP, UTP, and tUTP (all at 10 lM; n = 5 to 7). ⁄⁄Si
test). (C) Concentration response curves for the number of action potentials ﬁred in the
7.5 lM (ADP), 0.3 lM (UTP), and 0.63 lM (tUTP). (D) Concentration response curves for
EC50 values were: 0.8 lM (ATP), 2.2 lM (ADP), 0.5 lM (UTP), 1.2 lM (tUTP). (E) Total num
(10 lM) either applied alone or together with MRS2179 (30 lM; n = 5). ⁄⁄Signiﬁcant differ
response to current injections in the presence of tUTP (10 lM) either applied alone or to
response to current injections in the presence of ADP (10 lM), tUTP (10 lM), or A
ATP = adenosine triphosphate; tUTP = 2-thio-UTP; UDP = uridine diphosphate; UTP = urireturned to the levels observed prior to the application of the
nucleotide (Fig. 1A). Thus, ATP signiﬁcantly and reversibly en-
hanced the excitability of DRG neurons.
For comparison, 10 lM of ADP, UDP, UTP, or thio-UTP were ap-
plied to DRG neurons instead of ATP; ADP, UTP, and 2-thio-UTP
caused effects equivalent to those observed for ATP, whereas
UDP hardly caused any change (Fig. 1B). The effects of the nucleo-
tides on both the membrane potential and the number of elicited
action potentials were concentration dependent, with ATP, UTP,
and thio-UTP being more potent than ADP (Fig. 1C and D).
3.2. The effects of nucleotides are mediated by 2 separate receptors
None of the cloned P2Y receptors accept ADP and UTP as ago-
nists acting at a similar range of concentrations [43]. Moreover,
2-thio-UTP is a P2Y2-preferring agonist [17], and ADP does not
activate P2Y2 [43]. Therefore, we assumed that the actions of the
4 nucleotides, as described above, were mediated by at least 2 sep-
arate P2Y receptors. Because ADP is an agonist at P2Y1 receptors,
and these receptors are expressed in a large number of different
neurons [21], ADP was applied together with 30 lM of the speciﬁc
P2Y1 antagonist MRS 2179 [43]. In fact, the number of action
potentials triggered by current injections in the presence of
10 lM ADP was signiﬁcantly reduced by MRS 2179 (Fig. 1E),
whereas this antagonist had no effect on the number of action
potentials triggered in the presence of 10 lM 2-thio-UTP
(Fig. 1F). Thus, ADP and 2-thio-UTP acted via different receptors.
Nevertheless, the excitatory effects mediated by these 2 receptors
were not additive, as the combination of ADP and 2-thio-UTP
raised the number of action potential to a similar extent as the sep-
arated application of these nucleotides (Fig. 1G).otides. Membrane potential was measured in perforated patch current clamp mode,
plied. Nucleotides were present for 2 minutes before determining their effects. (A)
0 lM ATP. (B) Total number of action potentials ﬁred in response to the 5 current
gniﬁcant difference vs the effects of all other nucleotides at P < .01 (Kruskal–Wallis
presence of nucleotides (n = 5 to 8). Calculated EC50 values were: 0.45 lM (ATP),
the membrane depolarization in the presence of nucleotides (n = 5 to 8). Calculated
ber of action potentials ﬁred in response to current injections in the presence of ADP
ence at P < .01 (Mann–Whitney U test). (F) Total number of action potentials ﬁred in
gether with MRS2179 (30 lM; n = 5). (G) Total number of action potentials ﬁred in
DP co-applied with tUTP (both at 10 lM; n = 5). ADP = adenosine diphosphate;
dine triphosphate.
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nucleotides
Knowing that ADP and 2-thio-UTP elicited excitatory effects via
2 separate P2Y receptors, ADP was used ﬁrst to further investigate
the underlying mechanisms. In current clamp experiments, ADP
(10 lM) slowly reduced nondesensitizing outward currents at
holding potentials more positive than 60 mV (not shown), as pre-
viously observed in sympathetic neurons [6]; this is indicative of
an effect on KV7 channels. Therefore, the gating of these channels
was assessed by applying hyperpolarizing voltage steps from a
holding potential of 30 mV where KV7 channels are open to
55 mV in order to close the channels (Fig. 2A). ADP (10 lM)
slowly reduced the holding currents at 30 mV as well as the slow
deactivation of the current through KV7 channels (M current; IM) as
observed at 55 mV (Fig. 2A). The reduction of outward currents at
30 mV by ADP reached a maximum after 30 seconds, and these
currents returned to control values within 1 minute after removal
of the nucleotide (Fig. 2B). This effect was also seen with 10 lM
ATP and UTP, as well as with 10 lM of the selective P2Y2 agonist
2-thio-UTP (Fig. 2C). In concentration-response curves for the inhi-
bition of IM, ATP turned out to be more potent than ADP, UTP, and
2-thio-UTP (Fig. 2E).
At least ATP might also induce inward currents in DRG neurons
through an activation of P2X receptors. To reveal whether P2X
might be involved in the slow induction of apparent inward cur-
rents as observed at 30 mV (Fig. 2B), the nucleotides were also
applied to neurons clamped at 70 mVwhere KV7 channels are en-
tirely inactivated [10]. Under these conditions, ATP, but not ADP,
UTP, nor 2-thio-UTP (each at a concentration of 10 lM), causedFig. 2. Inhibition of currents through KV7 channels by different nucleotides. Currents w
30 mV and hyperpolarized to 55 mV for 1-second periods. (A) Original traces obtaine
dotted line indicates the zero current level. (B) Time course of the inhibition of the curre
ﬁrst amplitude determined in the same neuron (n = 5). (C) Inhibition of currents throug
presence of ATP, ADP, UDP, UTP, and tUTP (all at 10 lM; n = 9). ⁄⁄Signiﬁcant difference vs
currents through KV7 channels (IM) in capsaicin-insensitive neurons in the presence o
inhibition of currents through KV7 channels by different nucleotides (n = 5 to 9). All value
Calculated EC50 values were: 1.6 lM (ADP), 0.2 lM (ATP), 2.3 lM (UTP), and 1.1 lM (tUTP
alone or together with MRS2179 (30 lM; n = 8). ⁄⁄Signiﬁcant difference at P < .01 (Man
(10 lM) either applied alone or together with MRS2179 (30 lM; n = 5). (H) Inhibition of c
with tUTP (both at 10 lM; n = 5). ADP = adenosine diphosphate; ATP = adenosine triphorapidly activating inward currents that reached maximal ampli-
tudes within 6100 ms and largely desensitized within the next
2 seconds (Supplementary Fig. 1A and B). Thus, the slow effects
on KV7 channels described above can be easily discerned from ac-
tions mediated by P2X receptors. Moreover, ATP did reduce IM at
concentrations (such as 0.1 lM; Fig. 2E) that were too low to acti-
vate P2X receptors (not shown).
To learn whether the inhibition of KV7 channels by nucleotides
is speciﬁc for nociceptive neurons, ADP and 2-thio-UTP were also
applied to capsaicin-insensitive neurons. There, the reduction of
IM deactivation amplitudes was as pronounced as in capsaicin-sen-
sitive neurons (compare Fig. 2C and D).
The inhibition of IM by ADP (Fig. 2F), but not that by 2-thio-UTP
(Fig. 2G), was largely reduced by the P2Y1 antagonist MRS 2179.
Thus, 2 separate P2Y receptors mediate an inhibition of KV7
channels in sensory neurons. Nevertheless, the effects of ADP and
2-thio-UTP on IM were not additive (Fig. 2H).
3.4. Phospholipase C and increase in intracellular Ca2+ mediate the
inhibition of KV7 channels by nucleotides
To investigate the underlying signaling mechanisms, ADP and
2-thio-UTP were used as agonists for the 2 different receptors.
All P2Y receptors with the exception of P2Y12,13,14 couple to Gq
proteins and thereby to phospholipase C (PLC) [43]. When DRG
neurons were treated with 1 lM of the PLC inhibitor U73122
[23] for 15 minutes, the inhibition by either ADP or 2-thio-UTP
was signiﬁcantly smaller than prior to this treatment. Furthermore,
treatment of the neurons with 1 lM of the Ca2+-ATPase inhibitor
thapsigargin [39] for 15 minutes or with 10 lM of the cellere determined in perforated patch voltage clamp mode; neurons were clamped to
d before (control), during (ADP), and after (wash) the presence of 10 lM ADP. The
nt measured at 30 mV by 10 lM ADP; current amplitudes were normalized to the
h KV7 channels (IM; determined by the deactivation of currents at 55 mV) in the
the effects of all other nucleotides at P < .01 (Kruskal–Wallis test). (D) Inhibition of
f ADP and tUTP (both at 10 lM; n = 5). (E) Concentration response curves for the
s of inhibition were normalized to that evoked by 10 lM ADP in the very same cell.
). (F) Inhibition of currents through KV7 channels (IM) by ADP (10 lM) either applied
n–Whitney U test). (G) Inhibition of currents through KV7 channels (IM) by tUTP
urrents through KV7 channels (IM) by ADP (10 lM), tUTP (10 lM), or ADP co-applied
sphate; tUTP = 2-thio-UTP; UDP = uridine diphosphate; UTP = uridine triphosphate.
Fig. 3. The inhibition of currents through KV7 channels by nucleotides involves phospholipase C and increases in intracellular Ca2+. Currents were determined in perforated
patch voltage clampmode; neurons were clamped to 30 mV and hyperpolarized to 55 mV for 1-second periods. (A) Original traces obtained before (control), during (ADP),
and after (wash) the presence of 10 lM ADP; these measurements were performed before and at the end of a 15-minute application of U73122 (1 lM) followed by a ﬁnal
application of XE991 (10 lM). (B and C) Effects of U73122 (1 lM), thapsigargin (Thaps; 1 lM), BAPTA-AM (10 lM) and GF109203X (GFX; 1 lM) on the inhibition of currents
through KV7 channels (IM) by either ADP (10 lM in B) or tUTP (10 lM in C); the inhibition of IM by the nucleotides was determined before (pre) and at the end (post) of 15-
minute applications of U73122, thapsigargin, or GF109203X or of 30-minute applications of BAPTA-AM (n = 4 to 7). Signiﬁcant differences were found between the results
obtained before and after the application of U73122, thapsigargin, GF109203X, or BAPTA-AM at ⁄P < .05, ⁄⁄P < .01, and ⁄⁄⁄P < .001 (Mann–Whitney U test). ADP = adenosine
diphosphate; ATP = adenosine triphosphate; tUTP = 2-thio-UTP; UDP = uridine diphosphate; UTP = uridine triphosphate.
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IM by the 2 nucleotides when compared with the pretreatment sit-
uation (Fig. 3B and C). Thus, inhibition of PLC, depletion of intracel-
lular Ca2+ stores, and chelation of intracellular Ca2+ prevented the
inhibition of KV7 channels by nucleotides.
The PLC-mediated synthesis of inositol trisphosphate together
with increases in intracellular Ca2+ can lead to the activation of
Ca2+-dependent protein kinase C (PKC) isoforms that might be in-
volved in the inhibition of KV7 channels. However, the speciﬁc
PKC inhibitor GF 109203X [29] at a concentration of 1 lM did
not alter the inhibition of KV7 channels by either ADP or 2-thio-
UTP (Fig. 3B and C).
3.5. Two separate receptors mediate a sensitization of TRPV1 channels
by nucleotides
The sensitization of TRPV1 channels by inﬂammatory mediators
is believed to contribute to the development of chronic pain [22];
nucleotides have been reported to cause sensitization of TRPV1
[40,31]. Hence, ADP and 2-thio-UTP as agonists for the 2 separate
functional P2Y receptors in DRG neurons as identiﬁed above were
used to reveal whether these 2 P2Y receptors might also be linked
to TRPV1 channels. Indeed, currents evoked by 0.3 lM capsaicin
were markedly enhanced in the presence of 10 lM ADP (Fig. 4A).
This effect of ADP developed slowly and reached its maximum after
94.7 ± 19.5 seconds (n = 4). In concentration-response curves for
capsaicin-induced currents, this enhancement was revealed to be
due to a leftward shift in the presence of the nucleotide; 2-thio-
UTP caused a leftward shift similar to that observed for ADP
(Fig. 4B). ADP and 2-thio-UTP were about equipotent in potentiat-
ing capsaicin-evoked currents with half maximal effects at around
1 lM (Fig. 4C). The potentiation by ADPwas attenuated in the pres-
ence of the P2Y1 antagonist MRS 2179 (Fig. 4D), whereas the effect
of 2-thio-UTP remained unaltered (Fig. 4E). Thus, the 2 separate
nucleotide receptors mediating the inhibition of KV7 channels also
mediated a sensitization of TRPV1 channels. Moreover, the effects of
ADP and 2-thio-UTP were not additive once again (Fig. 4F).3.6. Phospholipase C, increases in intracellular Ca2+, and protein kinase
C mediate the sensitization of TRPV1 channels by nucleotides
TRPV1 channels are believed to be tonically inhibited by phos-
phatidylinositol 4,5-bisphosphate (PIP2), and a depletion of PIP2
in the membrane thus leads to sensitization of the receptors. Alter-
natively, the sensitization can occur via an activation of PKC [34].
To analyze the signaling cascades that link the 2 P2Y receptors to
TRPV1 channels, the manipulations used to investigate the inhibi-
tion of KV7 channels were used again. As observed in those exper-
iments, inhibition of PLC by 1 lM U73122 prevented the
facilitation of capsaicin-evoked currents by either ADP or 2-thio-
UTP (Fig. 5A–C).
The depletion of intracellular Ca2+ stores by thapsigargin and
the chelation of intracellular Ca2+ by BAPTA-AM also abolished
the sensitization of TRPV1 channels by the nucleotides. Likewise,
when PKC was inhibited by GF 109203X, the facilitation of capsa-
icin-evoked currents by either ADP or 2-thio-UTP was largely re-
duced (Fig. 5B and C).
3.7. The increase in the excitability of DRG neurons involves KV7 and
TRPV1 channels
To test whether the increase in the excitability of DRG neurons
observed in the presence of nucleotides is brought about by the
inhibition of KV7 channels and/or by the sensitization of TRPV1
channels, the nucleotides were applied together with either ﬂupir-
tine, an activator of KV7 channels [10], XE991, an inhibitor of KV7
channels [10], and/or iodoresiniferatoxin, an antagonist at TRPV1
channels [2].
Flupirtine 100 lM hyperpolarized DRG neurons by about 5 mV
(Fig. 6C), but failed to signiﬁcantly reduce the small number of ac-
tion potentials ﬁred in response to the injection of depolarizing
currents with increasing amplitudes (0.1 to 0.5 nA) in the absence
of nucleotides (Fig. 6A and B). However, ﬂupirtine entirely pre-
vented action potential ﬁring in the presence of either 100 lM
ADP (Fig. 6A and B) or 10 lM 2-thio-UTP (Fig. 6B). In addition,
Fig. 4. Potentiation of currents through TRPV1 channels by different nucleotides. Currents were determined in perforated patch voltage clamp mode; neurons were clamped
to 70 mV, and capsaicin was applied for 15-second periods in the absence or presence of the indicated concentrations of nucleotides. (A) Original traces of currents evoked
by 0.3 lM capsaicin (caps) before (ctrl), during (ADP), and after (wash) the presence of 10 lM ADP; capsaicin was applied as indicated by the bars. (B) Concentration response
curves for the peak amplitudes of inward currents induced by the indicated concentrations of capsaicin in the absence (ctrl) or presence of 10 lM of ADP or tUTP (n = 5 to 6).
All values were normalized to the current evoked by 1 lM capsaicin in the absence of nucleotides in the very same cell (Icaps normalized). (C) Concentration response curves
for the potentiation of currents induced by capsaicin (0.3 lM) in the presence of the indicated concentrations of nucleotides (n = 4 to 6). Amplitudes in the presence of
nucleotides were expressed as percentage of the amplitudes recorded in their absence (% Icaps). (D) Potentiation of capsaicin-induced currents (Icaps) by ADP (10 lM) either
applied alone or together with MRS 2179 (30 lM; n = 6). ⁄⁄Signiﬁcant difference at P < .01 (Mann–Whitney U test). (E) Potentiation of capsaicin-induced currents (Icaps) by
tUTP (10 lM) either applied alone or together with MRS 2179 (30 lM; n = 5). (F) Potentiation of capsaicin-induced currents (Icaps) by ADP (10 lM), tUTP (10 lM), or ADP co-
applied with tUTP (n = 5). ADP = adenosine diphosphate; tUTP = 2-thio-UTP.
Fig. 5. The potentiation of currents through TRPV1 channels by nucleotides involves phospholipase C, increases in intracellular Ca2+, and protein kinase C. Currents were
determined in perforated patch voltage clamp mode; neurons were clamped to 70 mV. (A) Original traces obtained with 0.3 lM capsaicin (caps) in the absence (ctrl) or
presence of tUTP; these recordings were performed before and at the end of a 15-minute application of U73122 (1 lM). (B and C) Effects of U73122 (1 lM), thapsigargin
(1 lM), BAPTA-AM (10 lM), and GF109203X (1 lM) on the potentiation of currents through TRPV1 channels (Icaps) by either ADP (10 lM in B) or tUTP (10 lM in C); currents
were determined before (pre) and at the end (post) of 15-minute applications of U73122, thapsigargin (Thaps), or GF109203X (GFX) or of 30-minute applications of BAPTA-
AM (n = 4 to 7); ⁄Signiﬁcant differences between the results obtained before and after the application of U73122, thapsigargin, BAPTA-AM, or GF 109203X at P < .05 (Mann–
Whitney U test). ADP = adenosine diphosphate; tUTP = 2-thio-UTP.
1904 A. Yousuf et al. / PAIN

152 (2011) 1899–1908ﬂupirtine abolished the depolarizations caused by either of these 2
nucleotides (Fig. 6C).
XE991 at 10 lM, a concentration that fully blocks currents
through KV7 channels in DRG neurons [26], enhanced the action
potential ﬁring and caused depolarization of DRG neurons to about
the same extent as ADP or 2-thio-UTP (Fig. 6D and E). Nevertheless,in the presence of 10 lMXE991, the 2 nucleotides were still able to
further depolarize the neurons and to facilitate action potential ﬁr-
ing (Fig. 6D and E).
Iodoresiniferatoxin (0.3 lM), in contrast, did not alter action
potential ﬁring in the absence of nucleotides, but signiﬁcantly re-
duced the number of action potentials ﬁred in response to current
Fig. 6. Role of KV7 channels in the increase of membrane excitability caused by
nucleotides. Membrane potential was measured in perforated patch current clamp
mode, and 2-second current injections of increasing amplitudes (as shown in A)
were applied. Nucleotides and other drugs were applied for 2 minutes before
determining their effects. (A) Original traces obtained in the absence or presence of
ADP (100 lM) applied either alone or together with ﬂupirtine (both at 100 lM). (B)
Total number of action potentials ﬁred in response to current injections in the
absence (ctrl) or presence of ﬂupirtine (100 lM), ADP (100 lM), tUTP (10 lM), or
the nucleotides together with 100 lM ﬂupirtine (Flup; n = 6). ⁄⁄Signiﬁcant differ-
ence vs the effects of ADP or tUTP applied alone at P < .01 (Mann–Whitney U test).
(C) Changes in membrane potential in the presence of ﬂupirtine (100 lM), ADP
(100 lM), tUTP (10 lM), or the nucleotides together with 100 lM ﬂupirtine (Flup;
n = 6). ⁄Signiﬁcant difference vs the effects of ADP or tUTP applied alone at P < .05
(Mann–Whitney U test). (D) Total number of action potentials ﬁred in response to
current injections in the absence (ctrl) or presence of XE991 (10 lM), ADP
(100 lM), tUTP (10 lM), or the nucleotides together with XE991 (n = 6). ⁄Signiﬁcant
difference vs the effect of ADP or tUTP applied alone at P < .05 (Mann–Whitney U
test). (E) Changes in membrane potential in the presence of XE991 (10 lM), ADP
(100 lM), tUTP (10 lM), or the nucleotides together with XE991 (n = 6). ⁄Signiﬁcant
difference vs the effects of ADP or tUTP applied alone at P < .05 (Mann–Whitney U
test). ADP = adenosine diphosphate; tUTP = 2-thio-UTP.
Fig. 7. Role of TRPV1 channels in the increase of membrane excitability caused by
nucleotides. Membrane potential was measured in perforated patch current clamp
mode and 2-second current injections of increasing amplitudes (as shown in A)
were applied. Nucleotides and other drugs were applied for 2 minutes before
determining their effects. (A) Original traces obtained in the absence (ctrl) or
presence of ADP (100 lM) applied either alone or together with iodoresiniferatoxin
(I-RTX; 0.3 lM). (B) Total number of action potentials ﬁred in response to current
injections in the absence (ctrl) or presence of iodoresiniferatoxin (I-RTX; 0.3 lM),
ADP (100 lM), tUTP (10 lM), or the nucleotides together with iodoresiniferatoxin
(I-RTX). ⁄Signiﬁcant difference vs the effect of 100 lM ADP or 10 lM tUTP applied
alone at P < .05 (Mann–Whitney U test; n = 5 to 7). (C) Changes in membrane
potential in the presence of iodoresiniferatoxin (0.3 lM), ADP (100 lM), tUTP
(10 lM), or the nucleotides together with iodoresiniferatoxin (I-RTX). ⁄Signiﬁcant
difference vs the effect of 100 lM ADP or 10 lM tUTP applied alone at P < .05
(Mann–Whitney U test; n = 5 to 7). (D) Total number of action potentials ﬁred in
response to current injections in the presence of 10 lM XE991 (XE), 0.3 lM
iodoresiniferatoxin (I-RTX)), 100 lM ADP, or 10 lM tUTP applied either alone or in
combination. ⁄Signiﬁcant difference vs the effect of ADP or tUTP when co-applied
with XE991 at P < .05 (Mann–Whitney U test; n = 6 to 8). (E) Changes in membrane
potential in the presence of 10 lM XE991 (XE), 0.3 lM iodoresiniferatoxin (I-RTX)),
100 lM ADP, or 10 lM tUTP applied either alone or in combination. ⁄Signiﬁcant
difference vs the effect of ADP or tUTP when co-applied with XE991 at P < .05
(Mann–Whitney U test; n = 6 to 8). ADP = adenosine diphosphate; tUTP = 2-thio-
UTP.
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10 lM 2-thio-UTP (Fig. 7B). Moreover, iodoresiniferatoxin per se
did not alter the membrane potential, but signiﬁcantly reduced
the depolarizing effect of either ADP or 2-thio-UTP (Fig. 7C). Final-
ly, when applied in the continuing presence of XE991 (10 lM),
iodoresiniferatoxin prevented any depolarization and any
enhancement of action potential ﬁring by either ADP or 2-thio-
UTP (Fig. 7D and E). Thus, the blockade of KV7 channels and of
TRPV1 channels is sufﬁcient to abolish the excitation of DRG
neurons by nucleotides.
3.8. P2Y12 receptors mediate an inhibition of voltage-gated Ca
2+
channels in DRG neurons
Nucleotides have been suggested to reduce neurotransmission
from DRG neurons onto dorsal horn neurons by an inhibition of
voltage-activated Ca2+ channels, but it remained controversial
whether this effect was mediated by P2Y1 [20] or P2Y12 [28] recep-tors. To clarify this issue, voltage-activated Ca2+ currents were re-
corded in the absence and presence of ADP. The nucleotide
caused a signiﬁcant decrease in Ca2+ current amplitudes (Fig. 8A
and B), and this inhibitory effect was abolished by the P2Y12 recep-
tor antagonist cangrelor (1 lM), but not by the P2Y1 antagonist
MRS2179 (30 lM; Fig. 8A and B).
4. Discussion
Although it is ﬁrmly established that ionotropic ATP receptors
containing P2X3 subunits do contribute to the well-known algetic
effects of this nucleotide, the role of metabotropic P2Y receptors
has remained at least controversial, if not unclear [44]. Here, we
demonstrate that activation of both P2Y1 and P2Y2 receptors leads
to a marked increase in the excitability of DRG neurons; such an
Fig. 8. Inhibition of voltage-activated Ca2+ currents in sensory neurons by ADP.
Currents were determined in whole-cell voltage clamp mode; neurons were
clamped to 80 mV and depolarized to 10 mV for 30 ms at a frequency of 4 min1.
(A) Original traces obtained before, during (ADP), and after the application of 10 lM
ADP in either the absence (control) or presence of MRS2179 (30 lM) or cangrelor
(1 lM). (B) Effects of ADP on peak amplitudes of Ca2+ currents in either the absence
(no ligand) or presence of MRS2179 (30 lM) or cangrelor (1 lM; n = 8).
⁄, ⁄⁄Signiﬁcant difference vs the currents determined in the absence of ADP at
P < .05 and P < .01, respectively (Wilcoxon signed rank test). ADP = adenosine
diphosphate; tUTP = 2-thio-UTP.
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relate of enhanced nociceptive behavior [11,26]. Furthermore, the
results reveal that both an inhibition of KV7 channels and a poten-
tiation of TRPV1 channels are involved in the excitation of DRG
neurons via these 2 nucleotide receptors. The same signaling
mechanisms are involved in the excitatory actions of bradykinin
in DRG neurons [11,26,46].
ADP, ATP, UTP, and 2-thio-UTP enhanced action potential ﬁring
in response to current injections with the following order of ago-
nist potency: ATP = UTP = 2-thio-UTP > ADP. ADP is an agonist at
P2Y1,12,13 receptors [43], and the effects of ADP were largely atten-
uated by the selective P2Y1 receptor antagonist MRS 2179 [14],
which demonstrates the participation of this latter receptor. The
other nucleotides used are either poor or not at all agonists at
P2Y1 receptors [43]. Hence, another nucleotide receptor must have
contributed, and this was P2Y2 for the following reasons: (1) UDP
did not mimic the effects of UTP; thus, a role of P2Y6 can be ex-
cluded [43]. (2) ATP and UTP were about equipotent as observed
for rat P2Y2 and P2Y4 receptors [43]. (3) UTP and 2-thio-UTP were
equipotent; this only holds true for P2Y2, but not for P2Y4 receptors
[17]. Thus, the nucleotides enhanced the excitability of DRG neu-
rons via both P2Y1 and P2Y2 receptors.
Recombinant P2Y1,2,4,6 receptors mediate an inhibition of KV7
channels [7], and DRG neurons express KV7.2, KV7.3, and KV7.5
[10]. Most recently, acute nociception induced by bradykinin was
shown to involve inhibition of KV7 channels and activation of a
Ca2+-dependent chloride current [26]. Here, all the nucleotides
mentioned above reduced currents through KV7 channels, and
the action of ADP, but not that of 2-thio-UTP, was attenuated by
the P2Y1 antagonist MRS 2179. Thus, the activation of both P2Y1
and P2Y2 receptors contributed to the closure of KV7 channels.
However, we found no evidence for an induction of chloride cur-
rents by any of the nucleotides tested (not shown). The inhibition
of KV7 channels by both P2Y1 and P2Y2 has also been observed with
receptors heterologously expressed in sympathetic neurons [9].
TRPV1 channels mediate acute and chronic pain [22], and ADP
as well as 2-thio-UTP enhanced currents through these receptors;
this effect of ADP, but not that of 2-thio-UTP, was again antago-nized by MRS 2179. Hence, in contrast to what has been indicated
by previous experiments, it is not P2Y1 [40] or P2Y2 [31,27], but
both receptors that contribute to the sensitization of TRPV1 chan-
nels by nucleotides. The most likely reason for the conﬂicting inter-
pretations of previous results is the fact that a full range of
selective agonists and antagonists for these 2 receptors as em-
ployed here had not been used. Alternatively, the reason might
be species differences between rats and mice.
Both P2Y1 and P2Y2 receptors are linked to Gq proteins and
thereby to PLC [43]. In accordance with this, the PLC inhibitor
U73122 [23] prevented the effects of both ADP and 2-thio-UTP,
on KV7 channels as well as on TRPV1 channels. The actions of these
nucleotides on KV7 and TRPV1 channels were also abolished when
Ca2+-ATPases had been inhibited by thapsigargin [39] or when
intracellular Ca2+ had been chelated by BAPTA-AM; thus, increases
in intracellular Ca2+ were involved in both of these effects. Down-
stream of Ca2+, however, the signaling cascades linking the 2 P2Y
receptors to either KV7 channels or TRPV1 channels differed from
each other: the sensitization of TRPV1 channels was mediated by
an activation of protein kinase C, as indicated by the inhibitory ef-
fect of GF 109203X, whereas the inhibition of KV7 channels was not
altered by this PKC inhibitor. This bifurcated signaling pathway
was shared by both receptors, P2Y1 and P2Y2. As a consequence,
the simultaneous activation of both receptors by ADP and 2-thio-
UTP did not achieve larger effects than the activation of only one
of these receptors.
These results lead to the question of how P2Y receptor activa-
tion could modulate KV7 channels, on one hand, and TRPV1 chan-
nels, on the other hand. The inhibition of neuronal KV7 channels
by G-protein coupled receptors involves either depletion of mem-
brane PIP2, phosphorylation via PKC, or binding of intracellular
Ca2+ to channel-bound calmodulin. In sympathetic neurons, the
ﬁrst 2 mechanisms were shown to mediate KV7 channel inhibition
via M1 muscarinic receptors [16]; the latter mechanism has been
found to mediate the inhibition via bradykinin and P2Y receptors
[8,49]. The present results support this latter idea, as manipula-
tions that prevented increases in intracellular Ca2+ abolished the
effects of nucleotides on KV7 channels, but inhibition of PKC failed
to alter the effect of P2Y receptor activation.
Obviously, the facilitation of currents through TRPV1 channels
via P2Y receptors cannot involve Ca2+/calmodulin, as this signaling
entity, if anything, mediates the desensitization of TRPV1, but not a
sensitization [34]. However, PLC-mediated depletion of membrane
PIP2 [15] as well as activation of Ca2+-dependent PKC [42] are both
known to potentiate currents evoked by low, but not those evoked
by high, capsaicin concentrations. In accordance with both mecha-
nisms, the nucleotides caused a leftward shift in the concentration-
response curves of capsaicin-evoked currents. However, the fact
that prevention of increases in intracellular Ca2+ as well as inhibi-
tion of PKC abolished the sensitization of TRPV1 channels by ADP or
2-thio-UTP demonstrate a role of Ca2+-dependent PKC.
Because this latter result proves that activation of either P2Y1 or
P2Y2 leads to the activation of Ca2+-dependent PKC, which then
phosphorylates TRPV1, one has to ask why activated PKC did not
contribute to the inhibition of KV7 channels as previously reported
for the signaling cascade linking M1 muscarinic receptors to this
ion channel family [16]. The most likely explanation is offered by
the ﬁnding that Ca2+/calmodulin disrupts the association of KV7
channels and AKAP79/150, which is a prerequisite for the phos-
phorylation of KV7 channels by PKC [3].
The increase in action potential ﬁring in the presence of ADP or
2-thio-UTP was completely abolished in the presence of the
nonopioid analgesic ﬂupirtine, which is known to activate KV7
channels [45]. This appears to indicate that the entire increase in
excitability was mediated by the inhibition of the K+ channels.
However, the hyperpolarization of the neurons caused by ﬂupirtine
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independently of the interaction at KV7 channels. Hence, this set
of data does not unequivocally demonstrate that KV7 channels
were involved in the effects of the nucleotides on excitability and
membrane potential. However, blockage of KV7 channels by
XE991 depolarized DRG neurons and enhanced their excitability
to a similar extent as the activation of the 2 nucleotide receptors;
this veriﬁes that the closure of KV7 channels is sufﬁcient to depo-
larize DRG neurons and to enhance their excitability.
Nevertheless, the excitatory actions of ADP or 2-thio-UTP were
additive to that of XE991, which hints to a role of an additional
mechanism. In line with this conclusion, the TRPV1 antagonist iod-
oresiniferatoxin also attenuated the nucleotide-induced increase in
membrane excitability. Moreover, the effects of the nucleotides on
action potential ﬁring and membrane potential in the presence of
XE991 were entirely abolished by iodoresiniferatoxin. Hence, the
inhibition of KV7 channels as well as the sensitization of TRPV1
channels both contributed to the increase in excitability triggered
by the activation of either P2Y1 or P2Y2 receptors.
In contrast to the excitatory effects shown above, ADP has been
reported to elicit analgesic rather than proalgesic effects, and an
inhibition of transmembrane Ca2+ entry in DRG neurons was im-
plied as underlying mechanism [20]. The inhibition of VACCs was
ﬁrst suggested to be mediated by P2Y1 [20], whereas a later report
demonstrated a role of P2Y12 and/or P2Y13 receptors [28]. In accor-
dance with that latter result, we found that the inhibition of VACCs
by ADP was attenuated by the P2Y12 antagonist cangrelor, but not
by MRS2179. This conﬁrms that P2Y1 contributes to the sensation
of pain in concert with P2Y2, whereas analgesic effects are medi-
ated by P2Y receptors coupled to inhibitory G proteins [28].
Taken together, our results reveal that ATP may cause pain not
only by the activation of ionotropic P2X receptors, but also via P2Y2
receptors. In addition, the ATP degradation product ADP also con-
tributes to the sensation of pain as it activates P2Y1 receptors.
These 2 metabotropic nucleotide receptors share a bifurcated sig-
naling cascade to enhance the excitability of DRG neurons through
a twofold mechanism: an inhibition of KV7 channels through Ca2+/
calmodulin and a sensitization of TRPV1 channels via Ca2+-depen-
dent PKC. Because this bifurcated mechanism is also associated
with bradykinin B2 receptors, it may well be a general signal cas-
cade employed by painful mediators [11].Conﬂict of interest statement
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